Anthropic releases Claude Science, sees Claude Code level impact
Key Points:
- Anthropic has launched Claude Science, an AI application tailored to optimize its large language model for scientific laboratories, particularly in pharmaceutical research operations.
- The product marks a strategic move in Anthropic's broader ambition to influence the future of biology, supported by significant financial resources.
- Anthropic recently reported annualized sales of $42 billion and a valuation of $965 billion following a $65 billion funding round, surpassing most healthcare companies except Eli Lilly.
- The company’s previous AI tool, Claude Code, revolutionized the programming industry, and Anthropic expects Claude Science to have a similarly transformative impact on life sciences.
- Eric Kauderer-Abrams, head of life sciences at Anthropic, emphasized that the company views its work in biology as the most critical focus area.